Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
24.94
-0.72 (-2.81%)
At close: May 1, 2026, 4:00 PM EDT
24.46
-0.48 (-1.92%)
After-hours: May 1, 2026, 7:27 PM EDT
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $874.22 million as of May 1, 2026. Its market cap has increased by 1,335.20% in one year.
Market Cap
874.22M
Enterprise Value
721.69M
1-Year Change
1,335.20%
Ranking
Category
Stock Price
$24.94
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $874.22M, an increase of 65.35%. That is a compound annual growth rate of 25.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 874.22M | 58.09% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 909.75M |
| LB Pharmaceuticals | 901.28M |
| Sana Biotechnology | 882.87M |
| Evommune | 882.45M |
| MannKind | 876.98M |
| Janux Therapeutics | 872.33M |
| MeiraGTx Holdings | 870.96M |
| Theravance Biopharma | 864.31M |